
NHS implements novel Manchester BRC respiratory antifungal resistance test
Research funded by the NIHR Manchester Biomedical Research Centre (BRC) has led to UK-wide implementation of a novel NHS diagnostic test that uses pyrosequencing (a method of identifying genetic markers in DNA), to identify the right treatment for people with aspergillosis.
Continue reading full article: NHS implements novel Manchester BRC respiratory antifungal resistance test